| Dr Lindsay D Wilson-barlow, PHD | |
|
1208 E 3300 S, Slc, UT 84106-2522 | |
| (801) 483-1600 | |
| Not Available |
| Full Name | Dr Lindsay D Wilson-barlow |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 9 Years |
| Location | 1208 E 3300 S, Slc, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275985624 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 9606716-2501 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of the latest interim data from a Phase II, multi-center, randomized, dose-ranging clinical trial evaluating the safety and antiviral activity of MK-5172, for the treatment of chronic hepatitis C virus genotype 1 infection.
A new pilot study is getting underway in Rhode Island aimed at improving depression in nursing home rehabilitation patients, all through telemedicine. Geriatric mental health specialists from Rhode Island and The Miriam hospitals will work with patients in the Evergreen House Nursing Home and Rehabilitation Center in East Providence to test the program.
In the US, child-resistant packaging for most medications has contributed to the prevention of thousands of pediatric deaths. Nevertheless, over 500,000 calls are made to poison control centers each year after accidental ingestion of medications by young children, and the number of emergency department visits for unsupervised medication ingestions is rising.
New research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe COVID-19 infection. Compared to patients who died within 28 days of their COVID-19 diagnosis, patients who produced a wide range of S2-specific responses were more likely to survive.
› Verified 9 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of the latest interim data from a Phase II, multi-center, randomized, dose-ranging clinical trial evaluating the safety and antiviral activity of MK-5172, for the treatment of chronic hepatitis C virus genotype 1 infection.
A new pilot study is getting underway in Rhode Island aimed at improving depression in nursing home rehabilitation patients, all through telemedicine. Geriatric mental health specialists from Rhode Island and The Miriam hospitals will work with patients in the Evergreen House Nursing Home and Rehabilitation Center in East Providence to test the program.
In the US, child-resistant packaging for most medications has contributed to the prevention of thousands of pediatric deaths. Nevertheless, over 500,000 calls are made to poison control centers each year after accidental ingestion of medications by young children, and the number of emergency department visits for unsupervised medication ingestions is rising.
New research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe COVID-19 infection. Compared to patients who died within 28 days of their COVID-19 diagnosis, patients who produced a wide range of S2-specific responses were more likely to survive.
› Verified 9 days ago
| Entity Name | University Of Utah Behavioral Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740688613 PECOS PAC ID: 9537483607 Enrollment ID: O20150120001118 |
News Archive
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of the latest interim data from a Phase II, multi-center, randomized, dose-ranging clinical trial evaluating the safety and antiviral activity of MK-5172, for the treatment of chronic hepatitis C virus genotype 1 infection.
A new pilot study is getting underway in Rhode Island aimed at improving depression in nursing home rehabilitation patients, all through telemedicine. Geriatric mental health specialists from Rhode Island and The Miriam hospitals will work with patients in the Evergreen House Nursing Home and Rehabilitation Center in East Providence to test the program.
In the US, child-resistant packaging for most medications has contributed to the prevention of thousands of pediatric deaths. Nevertheless, over 500,000 calls are made to poison control centers each year after accidental ingestion of medications by young children, and the number of emergency department visits for unsupervised medication ingestions is rising.
New research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe COVID-19 infection. Compared to patients who died within 28 days of their COVID-19 diagnosis, patients who produced a wide range of S2-specific responses were more likely to survive.
› Verified 9 days ago
| Entity Name | University Of Utah Pediatric Behavioral Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649631599 PECOS PAC ID: 3870886898 Enrollment ID: O20160727002309 |
News Archive
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of the latest interim data from a Phase II, multi-center, randomized, dose-ranging clinical trial evaluating the safety and antiviral activity of MK-5172, for the treatment of chronic hepatitis C virus genotype 1 infection.
A new pilot study is getting underway in Rhode Island aimed at improving depression in nursing home rehabilitation patients, all through telemedicine. Geriatric mental health specialists from Rhode Island and The Miriam hospitals will work with patients in the Evergreen House Nursing Home and Rehabilitation Center in East Providence to test the program.
In the US, child-resistant packaging for most medications has contributed to the prevention of thousands of pediatric deaths. Nevertheless, over 500,000 calls are made to poison control centers each year after accidental ingestion of medications by young children, and the number of emergency department visits for unsupervised medication ingestions is rising.
New research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe COVID-19 infection. Compared to patients who died within 28 days of their COVID-19 diagnosis, patients who produced a wide range of S2-specific responses were more likely to survive.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lindsay D Wilson-barlow, PHD 6824 S Nye Dr, Salt Lake City, UT 84121-3114 Ph: (801) 690-3935 | Dr Lindsay D Wilson-barlow, PHD 1208 E 3300 S, Slc, UT 84106-2522 Ph: (801) 483-1600 |
News Archive
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of the latest interim data from a Phase II, multi-center, randomized, dose-ranging clinical trial evaluating the safety and antiviral activity of MK-5172, for the treatment of chronic hepatitis C virus genotype 1 infection.
A new pilot study is getting underway in Rhode Island aimed at improving depression in nursing home rehabilitation patients, all through telemedicine. Geriatric mental health specialists from Rhode Island and The Miriam hospitals will work with patients in the Evergreen House Nursing Home and Rehabilitation Center in East Providence to test the program.
In the US, child-resistant packaging for most medications has contributed to the prevention of thousands of pediatric deaths. Nevertheless, over 500,000 calls are made to poison control centers each year after accidental ingestion of medications by young children, and the number of emergency department visits for unsupervised medication ingestions is rising.
New research published on the preprint server bioRxiv* suggests S2-specific antibody responses are critical in recovering from mild to severe COVID-19 infection. Compared to patients who died within 28 days of their COVID-19 diagnosis, patients who produced a wide range of S2-specific responses were more likely to survive.
› Verified 9 days ago
Matthew Davis, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 501 S Chipeta Way, Slc, UT 84108 Phone: 801-583-2500 | |
Dr. Lara Leishman, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 231 E 400 S, Slc, UT 84111 Phone: 801-363-1189 Fax: 801-363-1198 | |
Dr. Melvin F. Nosanchuk, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1646 Kensington Ave, Slc, UT 84105 Phone: 801-467-4875 Fax: 801-467-4875 | |
Wendy Dawn Hoyt, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 349 E 900 S, Slc, UT 84111 Phone: 801-532-3614 | |
Dr. Tanya Michelle Miller, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 500 Foothill Dr, Slc, UT 84148 Phone: 801-582-1565 Fax: 801-584-2544 | |
Dr. Larry Brad Peck, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 44 N Medical Dr, Slc, UT 84113 Phone: 801-584-8533 |